Epsilogen: co-opting IgE antibodies against cancer Epsilogen Ltd was profiled in BioCentury’s Emerging Company Profile on June 5, 2020. See the article in full here
June 5, 2020 - Articles
Articles
June 18, 2018 - Articles
IGEM Therapeutics: Pursuing Novel IgE Antibodies For Solid Tumors
Emerging Company Profile: IGEM Therapeutics has been spun out of King’s College London to evaluate the use of IgE-based monoclonal antibodies for the treatment of cancer, including difficult-to-reach solid tumors…. ….. See the...
June 18, 2018 - Articles
Genetic Engineering News Article
Not to be Sneezed At One of the stand-out technologies discussed by London-based immuno-oncology start-up Epsilogen was in antibody therapeutics….. See the article in full here: ...